Vyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek
| 116.9 | C01CA24 | epinefrin | parent. | 0.5 | MG | 4,50 | O |
|---|---|---|---|---|---|---|---|
| 116.10 | C01CA14 | dopexamin | parent. | 500 | MG | 109,39 | H |
| 116.11 | C01CX08 | levosimendan | parent. | 11 | MG | 20280,00 | H |
| 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4059,95 | H |
| 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F | |||
| 117.2 | C01CE02 | milrinon | parent. | 50 | MG | 3980,00 | H |
| 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,00 | |
| 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 3,00 | |
| 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,12 | |
| 31089 | NITROMINT 2.6MG | tbl ret 60x2.6mg | EGI | H | |||
| 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 3,50 | |
| 02405 | DINISAN RETARD 20MG | por cps pro 30x20mg | ETS | F | |||
| 32840 | DINISAN RETARD 20MG | por cps pro 30x20mg | PMP | CZ | |||
| 118.5 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60 | MG | 1,25 | |
| 118.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60 | MG | 2,50 | |
| 02379 | DINISAN RETARD 40MG | por cps pro 30x40mg | ETS | F | |||
| 32843 | DINISAN RETARD 40MG | por cps pro 30x40mg | PMP | CZ | |||
| 118.7 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,20 | |
| 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D | |||
| 118.8 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 2,75 | |
| 47685 | ISMIN AL 20 | por tbl nob 30x20mg | APA | D | |||
| 47686 | ISMIN AL 20 | por tbl nob 60x20mg | APA | D | |||
| 47687 | ISMIN AL 20 | por tbl nob100x20mg | APA | D | |||
| 59898 | ISMN AL 20 | por tbl nob 30x20mg | APA | D | |||
| 92568 | ISMN AL 20 | por tbl nob 60x20mg | APA | D | |||
| 61467 | ISMN AL 20 | por tbl nob100x20mg | APA | D | |||
| 87184 | MONO MACK 20MG | por tbl nob 30x20mg | ICS | CZ | |||
| 96190 | MONOSAN 20 MG | por tbl nob 30x20mg | PMP | CZ | |||
| 96187 | MONOSAN 20 MG | por tbl nob 50x20mg | PMP | CZ | |||
| 23305 | MONOSAN 20 MG | por tbl nob100x20mg | PMP | CZ | |||
| 76402 | SORBIMON 20 MG | tbl 100x20mg | MCK | D | |||
| 76400 | SORBIMON 20 MG | tbl 20x20mg | MCK | D | |||
| 76401 | SORBIMON 20 MG | tbl 50x20mg | MCK | D | |||
| 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 2,49 | |
| 47688 | ISMIN AL 40 | por tbl nob 30x40mg | APA | D | |||
| 47689 | ISMIN AL 40 | por tbl nob 60x40mg | APA | D | |||
| 47690 | ISMIN AL 40 | por tbl nob100x40mg | APA | D | |||
| 59899 | ISMN AL 40 | por tbl nob 30x40mg | APA | D | |||
| 92569 | ISMN AL 40 | por tbl nob 60x40mg | APA | D | |||
| 61469 | ISMN AL 40 | por tbl nob100x40mg | APA | D | |||
| 87185 | MONO MACK 40MG | por tbl nob 30x40mg | ICS | CZ | |||
| 96191 | MONOSAN 40 MG | por tbl nob 30x40mg | PMP | CZ | |||
| 96188 | MONOSAN 40 MG | por tbl nob 50x40mg | PMP | CZ | |||
| 23306 | MONOSAN 40 MG | por tbl nob100x40mg | PMP | CZ | |||
| 76405 | SORBIMON 40 MG | tbl 100x40mg | MCK | D | |||
| 76403 | SORBIMON 40 MG | tbl 20x40mg | MCK | D | |||
| 76404 | SORBIMON 40 MG | tbl 50x40mg | MCK | D | |||
| 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,18 | H |
| 02640 | NITRO MACK AMPULE | inj 10x5ml/5mg | PHH | D | |||
| 04307 | NITRO POHL INFUS. | inf 10x10ml/10mg | PLB | D | |||
| 83538 | NITRO POHL INFUS. | inf 1x50ml/50mg | PLB | D | |||
| 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 123,96 | H |
| 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,36 | |
| 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 8,80 | |
| 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 5,93 | |
| 00231 | NITROGLYCERIN-SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK | |||
| 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,03 | |
| 122 | C01DX | ostatní vazodilatancia | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,79 | |
| 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 4,46 | |
| 49553 | MOLSIHEXAL 2 MG | tbl 100x2mg | SFS | D | |||
| 122.3 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 2,72 | |
| 49554 | MOLSIHEXAL 4 MG | tbl 100x4mg | SFS | D | |||
| 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,10 | |
| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | SFS | D | |||
| 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | SFS | D | |||
| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | SFS | D | |||
| 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 6,50 | L/INT, KAR,GER |
| 123 | C01DX | ostatní vazodilatancia | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 13,78 | H |
| 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 105,38 | H |
| 124 | C01EA | prostaglandiny | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3090,40 | X |
| 92305 | ALPROSTAN | inf sol 10x0.2ml | LEX | CZ | |||
| 44169 | ALPROSTAPINT 500 MCG/ML | inf cnc sol 5x1ml | BGD | D | |||
| 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 634,27 | X |
| 91731 | PROSTAVASIN | inj sic 10x5ml | SWP | D | |||
| 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 6,80 | |
| 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 7,00 | |
| 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 7,00 | |
| 125.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.3 | MG | 7,80 | |
| 125.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.3 | MG | 7,00 | |
| 125.6 | C02AC06 | rilmenidin | p.o. | 1 | MG | 7,00 | |
| 125.7 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,63 | |
| 02629 | CRYSTEPIN | drg 30 | LEX | CZ | |||
| 125.8 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 4,94 | |
| 125.9 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2 | DF | 3,42 | |
| 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 70,09 | H |
| 11823 | CATAPRESAN | inj 5x1ml/0.15mg | BOE | E | |||
| 92074 | CATAPRESAN | inj 5x1ml/0.15mg | BGP | D | |||
| 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 127.1 | C02CA | metazosin | p.o. | 20 | MG | 5,96 | |
| 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 12,59 | |
| 58259 | DEPRAZOLIN MITE | tbl 15x1mg | LEX | CZ | |||
| 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 3,33 | |
| 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ | |||
| 127.4 | C02CA04 | doxazosin-retardované formy do 4 mg v jedné tabletě včetně | p.o. | 4 | MG | 18,90 | L/URN |
| 127.5 | C02CA04 | doxazosin-retardované formy nad 4 mg v jedné tabletě | p.o. | 4 | MG | 10,20 | L/URN |
| 127.6 | C02CA04 | doxazosin – neretardované formy | p.o. | 4 | MG | 16,80 | L/URN |
| 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO | |||
| 64797 | KAMIREN 4 | tbl 30x4mg | KRK | SLO | |||
| 45215 | ZOXON 4 | por tbl nob 30x4mg | LEX | CZ | |||
| 95243 | ZOXON 4 | por tbl nob100x4mg | LEX | CZ | |||
| 127.7 | C02CA06 | urapidil | p.o. | 50 | MG | 6,89 | |
| 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 217,84 | O |
| 90763 | EBRANTIL I.V. 25 | inj sol 5x5ml/25mg | AKZ | D | |||
| 90765 | EBRANTIL I.V. 50 | inj sol 5x10ml/50mg | AKZ | D | |||
| 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 2,00 | |
| 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,43 | |
| 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,14 | L/INT,KAR, GER |
| 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 283,99 | H |
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 29,88 | H |
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 265,63 | H |
| 21221 | NIPRUSS | inf plv sol 5x60mg | SWP | D | |||
| 131 | C03AA | thiazidová diuretika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 131.1 | C03AA03 | hydrochlorothiazid | p.o. | 25 | MG | 0,94 | |
| 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 132.1 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,61 | |
| 132.2 | C03BA10 | xipamid | p.o. | 20 | MG | 1,03 | |
| 132.3 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,12 | |
| 96696 | INDAP | por cps dur30x2.5mg | PMP | CZ | |||
| 46635 | INDAPAMID HF | tbl obd 30x2.5mg | HMF | YU | |||
| 132.4 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,12 | |
| 132.5 | C03BA | metipamid | p.o. | 2.5 | MG | 1,03 | |
| 132.6 | C03B | cikletanin | p.o. | 50 | MG | 1,03 | |
| 133 | C03CA | kličková diuretika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,88 | |
| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | |||
| 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND | |||
| 98219 | FURON 40 MG | por tbl nob 50x40mg | MCK | D | |||
| 56805 | FURORESE 40 | tbl 100x40mg | FST | D | |||
| 56802 | FURORESE 40 | tbl 20x40mg | FST | D | |||
| 56804 | FURORESE 40 | tbl 50x40mg | FST | D | |||
| 02079 | FUROSEMID-SLOVAKOFARMA | tbl 20x40mg | SLO | SK | |||
| 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,08 | |
| 56809 | FURORESE 125 | tbl 100x125mg | FST | D | |||
| 56807 | FURORESE 125 | tbl 30x125mg | FST | D | |||
| 56808 | FURORESE 125 | tbl 50x125mg | FST | D | |||
| 98937 | FURORESE 250 | por tbl nob10x250mg | FST | D | |||
| 56810 | FURORESE 250 | por tbl nob20x250mg | FST | D | |||
| 56811 | FURORESE 250 | por tbl nob50x250mg | FST | D | |||
| 56812 | FURORESE 250 | por tblnob100x250mg | FST | D | |||
| 56815 | FURORESE 500 | tbl 100x500mg | FST | D | |||
| 68632 | FURORESE 500 | tbl 20x500mg | FST | D | |||
| 56814 | FURORESE 500 | tbl 50x500mg | FST | D | |||
| 81497 | FUROSEMID AL 500 | por tbl nob20x500mg | APA | D | |||
| 81498 | FUROSEMID AL 500 | por tbl nob50x500mg | APA | D | |||
| 81499 | FUROSEMID AL 500 | por tblnob100x500mg | APA | D | |||
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | |||
| 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,88 | |
| 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,08 | |
| 134 | C03CA | kličková diuretika | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 15,04 | O |
| 56818 | FURORESE 20 INJEKT | inj 25x2ml/20mg | PHH | D | |||
| 56817 | FURORESE 20 INJEKT | inj 5x2ml/20mg | PHH | D | |||
| 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | HBS | SK | |||
| 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,36 | O |
| 56820 | FURORESE ROZTOK | inf 25x25ml/250mg | PHH | D | |||
| 56819 | FURORESE ROZTOK | inf 5x25ml/250mg | PHH | D | |||
| 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK | |||
| 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 16,03 | O |
| 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 7,72 | O |
| 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 543,63 | O |
| 135 | C03D | kalium šetřící diuretika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 4,84 | |
| 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,56 | |
| 87662 | AMICLARAN | tbl 50x5mg | SLO | SK | |||
| 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,22 | |
| 136 | C03EA | kombinace thiazidových a kalium šetřících diuretik | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 136.1 | C03EA06 | chlorthalidon a kalium šetřící látky | p.o. | 1 | DF | 1,17 | |
| 88518 | AMICLOTON | tbl 30 | SLO | SK | |||
| 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,54 | |
| 83718 | AMILORID/HCT AL | tbl 100 | APA | D | |||
| 83717 | AMILORID/HCT AL | tbl 50 | APA | D | |||
| 47478 | LORADUR MITE | por tbl nob 50 | MCK | D | |||
| 76380 | RHEFLUIN | tbl 30 | LEX | CZ | |||
| 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 9,78 | |
| 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 20,82 | O |
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 87,00 | O |
| 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 138.1 | C04AC01 | kyselina nikotinová | p.o. | 0.2 | GM | 0,44 | |
| 138.2 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 4,30 | |
| 138.3 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 4,30 | |
| 138.4 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 6,70 | |
| 54247 | APO-PENTOXIFYLLINE SR | por tblpro100x400mg | APT | CND | |||
| 47085 | PENTOMER RETARD 400MG | tbl ret 100x400mg | MCK | D | |||
| 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl ret 100x400mg | APA | D | |||
| 66513 | PENTOXIFYLLIN AL 400 RETARD | tbl ret 30x400mg | APA | D | |||
| 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl ret 50x400mg | APA | D | |||
| 53479 | TRENTAL 400 | por tbl ret20x400mg | HBS | SK | |||
| 53480 | TRENTAL 400 | por tblret100x400mg | HBS | SK | |||
| 138.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 7,50 | |
| 49600 | PENTOHEXAL 600 | tbl ret 30x600mg | SFS | D | |||
| 49601 | PENTOHEXAL 600 | tbl ret 50x600mg | SFS | D | |||
| 97702 | PENTOMER RETARD 600MG | tbl ret 20x600mg | MCK | D | |||
| 84413 | VASONIT RETARD 600MG | tbl obd 20x600mg | LAR | A | |||
| 138.6 | C04AD04 | etophyllin nikotinát | p.o. | 0.3 | GM | 1,65 | |
| 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK | |||
| 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 139.1 | C04AC | olamin nikotinát | parent. | 0.9 | GM | 20,04 | |
| 139.2 | C04AD | etophyllin/theophyllin | parent. | 0.3 | GM | 11,05 | |
| 57351 | OXANTIL | inj 5x2ml | HBS | SK | |||
| 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,25 | |
| 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 28,40 | |
| 53200 | AGAPURIN | inj 5x5ml/100mg | SLO | SK | |||
| 69241 | PENTILIN INJEKCE 100MG/5ML | inj 5x5ml/100mg | KRK | SLO | |||
| 49603 | PENTOHEXAL 300 | inf 10x15ml/300mg | PHH | D | |||
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | |||
| 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,11 | |
| 91032 | SECATOXIN FORTE | por gtt sol 1x25ml | IVX | CZ | |||
| 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,50 | |
| 05742 | ERGOTOP 30 | por tbl flm 28x30mg | IVX | CZ | |||
| 140.3 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2 | ML | 1,87 | |
| 88088 | ERSILAN | gtt 1x50ml | GNO | CZ | |||
| 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 69,21 | |
| 142 | C04AX | jiná periferní vasodilatancia | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,66 | |
| 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,54 | |
| 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,66 | |
| 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,66 | |
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,66 | |
| 66015 | ENELBIN 100 RETARD | por tblret100x100mg | LEX | CZ | |||
| 143 | C04AX | jiná periferní vasodilatancia | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 14,86 | |
| 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 51,52 | |
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 53,95 | |
| 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ | |||
| 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 144.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1 | GM | 0,81 | |
| 144.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 144.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1 | GM | 0,81 | |
| 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,84 | |
| 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 145.1 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
| 145.2 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 145.3 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
| 145.4 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 146.1 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,87 | |
| 146.2 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,87 | |
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | |||
| 86042 | HEPARIN AL MAST 30000 | ung 1x100gm | APA | D | |||
| 146.3 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1 | GM | 0,87 | |
| 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 147.1 | C05CA04 | troxerutin | p.o. | 3 | DF | 4,50 | |
| 147.2 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,30 | |
| 96303 | ASCORUTIN | tbl obd 50 | SLO | SK | |||
| 147.3 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,03 | |
| 02635 | ANAVENOL | por gtt sol 1x25ml | IXP | CZ | |||
| 147.4 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 4,50 | |
| 147.5 | C05CA54 | troxerutin, kombinace | p.o. | 2 | DF | 4,50 | |
| 148 | C05 | jiné kapiláry stabilizující látky | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 148.1 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 4,50 | |
| 148.2 | C05CX01 | tribenosid | p.o. | 0.8 | GM | 4,50 | |
| 148.3 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,33 | |
| 31000 | YELLON | cps 30x20mg-bli | SLO | SK | |||
| 94327 | YELLON | cps 30x20mg-lah | SLO | SK | |||
| 149 | C05 | jiné kapiláry stabilizující látky | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 54,26 | H |
| 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,16 | O |
| 08512 | AETHOXYSKLEROL 0.5% | inj 1x30ml | KRS | D | |||
| 08510 | AETHOXYSKLEROL 0.5% | inj 5x2ml | KRS | D | |||
| 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,30 | O |
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml | KRS | D | |||
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml | KRS | D | |||
| 149.4 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1 | ML | 18,16 | O |
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml | KRS | D | |||
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml | KRS | D | |||
| 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 19,64 | O |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml | KRS | D | |||
| 149.6 | C05BB04 | natrium tetradecyl sulfat (koncentrace do 1% včetně) | parent. | 1 | ML | 14,16 | O |
| 149.7 | C05BB04 | natrium tetradecyl sulfat (koncentrace nad 1% ) | parent. | 1 | ML | 19,64 | O |
| 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 150.1 | C07AA07 | sotalol | p.o. | 0.16 | GM | 4,75 | L/KAR,INT, GER |
| 83481 | SOTAHEXAL 160 | tbl 20x160mg | HEX | D | |||
| 83670 | SOTAHEXAL 160 | tbl 50x160mg | HEX | D | |||
| 83480 | SOTAHEXAL 80 | tbl 20x80mg | HEX | D | |||
| 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 151.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,78 | |
| 151.2 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,66 | |
| 02483 | TRIMEPRANOL 10MG | tbl 50x10mg | SLO | SK | |||
| 151.3 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,29 | |
| 151.4 | C07AA02 | oxprenolol | p.o. | 0.1 | GM | 2,74 | |
| 151.5 | C07AA03 | pindolol | p.o. | 15 | MG | 2,74 | |
| 151.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,74 | |
| 151.7 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2,74 | |
| 151.8 | C07AA16 | tertatolol | p.o. | 5 | MG | 2,74 | |
| 151.9 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,00 | |
| 151.10 | C07AA23 | penbutolol | p.o. | 40 | MG | 2,74 | |
| 151.11 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,74 | |
| 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 152.1 | C07AA | metipranolol | parent. | 10 | MG | 62,70 | O |
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | |||
| 152.2 | C07AA | talinolol | parent. | 50 | MG | 93,65 | O |
| 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 99,13 | O |
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99,13 | O |
| 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 900,64 | O |
| 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 153.1 | C07AB02 | metoprolol (do 50 mg včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,93 | |
| 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND | |||
| 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H | |||
| 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H | |||
| 50080 | VASOCARDIN 50 | tbl 50x50mg | SLO | SK | |||
| 153.2 | C07AB02 | metoprolol (nad 50 mg v jedné tabletě) | p.o. | 0.15 | GM | 2,74 | |
| 96755 | APO-METOPROLOL 100 | tbl 100x100mg | APT | CND | |||
| 45555 | BETALOC 100 MG | tbl 100x100mg | AZC | S | |||
| 59894 | EGILOK 100 MG | tbl 200x100mg | EGI | H | |||
| 59893 | EGILOK 100 MG | tbl 60x100mg | EGI | H | |||
| 32674 | METOPROLOL AL 100 | por tbl nob20x100mg | SDB | D | |||
| 47673 | METOPROLOL AL 100 | por tbl nob20x100mg | APA | D | |||
| 47674 | METOPROLOL AL 100 | por tbl nob60x100mg | APA | D | |||
| 32675 | METOPROLOL AL 100 | por tblnob100x100mg | SDB | D | |||
| 47675 | METOPROLOL AL 100 | por tblnob100x100mg | APA | D | |||
| 45592 | VASOCARDIN 100 | tbl 50x100mg-blistr | SLO | SK | |||
| 153.3 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 3,52 | |
| 46980 | BETALOC SR 200MG | tbl ret 100x200mg | AZC | S | |||
| 46981 | BETALOC SR 200MG | tbl ret 30x200mg | AZC | S | |||
| 03201 | EMZOK 200 MG | por tbl pro30x200mg | IXP | CZ | |||
| 32673 | METOPROLOL AL 200 RETARD | por tbl pro50x200mg | APA | D | |||
| 47501 | METOPROLOL AL 200 RETARD | por tblpro100x200mg | APA | D | |||
| 32707 | VASOCARDIN SR 200 | por tbl pro30x0.2gm | SLO | SK | |||
| 32711 | VASOCARDIN SR 200 | por tblpro100x0.2gm | SLO | SK | |||
| 153.4 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 26,20 | P |
Metoprolol v lékové formě tablet s řízeným uvolňováním je ordinován k léčbě srdečního selhání; v dávce 25 mg je určen k zahájení léčby, pouze v případech kdy není pacinetem tolerována dávka vyšší, je možné podávat v dávce 25 mg dlouhodobě. Cílová dávka metoprololu v lékové formě tablet s řízeným uvolňováním v indikaci srdečního selhání je 200 mg denně, k této udržovací dávce je možné předepisovat tablety s obsahem 100 mg. V indikaci léčby hypertenze, arytmií a sekundární prevence nelze hradit ze zdravotního pojištění.
| 31536 | BETALOC ZOK 25 MG | tbl ret 100x25mg | AZC | S | |||
|---|---|---|---|---|---|---|---|
| 49935 | BETALOC ZOK 25 MG | tbl ret 100x25mg | AZC | D | |||
| 153.5 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 8,00 | P |
| 153.6 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně | p.o. | 75 | MG | 3,35 | |
| 42453 | ATEHEXAL 25 | por tbl flm 30x25mg | SFS | D | |||
| 83638 | ATEHEXAL 25 | por tbl flm 30x25mg | HEX | D | |||
| 42454 | ATEHEXAL 25 | por tbl flm 50x25mg | SFS | D | |||
| 83639 | ATEHEXAL 25 | por tbl flm 50x25mg | HEX | D | |||
| 42455 | ATEHEXAL 25 | por tbl flm100x25mg | SFS | D | |||
| 83640 | ATEHEXAL 25 | por tbl flm100x25mg | HEX | D | |||
| 42456 | ATEHEXAL 50 | por tbl flm 30x50mg | SFS | D | |||
| 83642 | ATEHEXAL 50 | por tbl flm 30x50mg | HEX | D | |||
| 42457 | ATEHEXAL 50 | por tbl flm 50x50mg | SFS | D | |||
| 83643 | ATEHEXAL 50 | por tbl flm 50x50mg | HEX | D | |||
| 42458 | ATEHEXAL 50 | por tbl flm100x50mg | SFS | D | |||
| 83644 | ATEHEXAL 50 | por tbl flm100x50mg | HEX | D | |||
| 62861 | ATENOBENE 25 MG | por tbl flm 30x25mg | MCK | D | |||
| 62856 | ATENOBENE 50 MG | por tbl flm 20x50mg | MCK | D | |||
| 62857 | ATENOBENE 50 MG | por tbl flm 50x50mg | MCK | D | |||
| 58659 | ATENOLOL AL 25 | por tbl nob 30x25mg | APA | D | |||
| 58660 | ATENOLOL AL 25 | por tbl nob 50x25mg | APA | D | |||
| 58661 | ATENOLOL AL 25 | por tbl nob100x25mg | APA | D | |||
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D | |||
| 89253 | ATENOLOL AL 25 | tbl obd 50x25mg | APA | D | |||
| 89252 | ATENOLOL AL 25 | tblobd 30x25mg | APA | D | |||
| 02949 | ATENOLOL AL 50 | por tbl nob 30x50mg | APA | D | |||
| 02950 | ATENOLOL AL 50 | por tbl nob 50x50mg | APA | D | |||
| 02951 | ATENOLOL AL 50 | por tbl nob100x50mg | APA | D | |||
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D | |||
| 89255 | ATENOLOL AL 50 | tbl obd 30x50mg | APA | D | |||
| 89256 | ATENOLOL AL 50 | tbl obd 50x50mg | APA | D | |||
| 153.7 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75 | MG | 3,10 | |
| 54419 | ATEBLOCOR 100 | por tbl flm30x100mg | PMP | CZ | |||
| 42459 | ATEHEXAL 100 | por tbl flm30x100mg | SFS | D | |||
| 83646 | ATEHEXAL 100 | por tbl flm30x100mg | HEX | D | |||
| 42460 | ATEHEXAL 100 | por tbl flm50x100mg | SFS | D | |||
| 83647 | ATEHEXAL 100 | por tbl flm50x100mg | HEX | D | |||
| 42461 | ATEHEXAL 100 | por tblflm100x100mg | SFS | D | |||
| 83648 | ATEHEXAL 100 | por tblflm100x100mg | HEX | D | |||
| 02710 | ATENOLOL AL 100 | por tblnob 50x100mg | APA | D | |||
| 02720 | ATENOLOL AL 100 | por tblnob100x100mg | APA | D | |||
| 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D | |||
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D | |||
| 65389 | TENORMIN 100 | tbl obd 28x100mg | AZC | GB | |||
| 153.8 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 5,12 | |
| 75939 | ACECOR 400 | por tbl flm30x400mg | DAQ | I | |||
| 153.9 | C07AB05 | betaxolol | p.o. | 20 | MG | 5,12 | |
| 153.10 | C07AB07 | bisoprolol | p.o. | 10 | MG | 5,12 | |
| 32970 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D | |||
| 32974 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | |||
| 32967 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | |||
| 32963 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D | |||
| 153.11 | C07AB07 | bisoprolol hemifumarát do 2,5 mg v jedné tabletě včetně | p.o. | 10 | MG | 13,37 | P |
| 03801 | CONCOR COR 2.5 MG | tbl obd 28x2.5mg | MEC | D | |||
| 153.12 | C07AB07 | bisoprolol hemifumarát nad 2,5 mg v jedné tabletě | p.o. | 10 | MG | 8,00 | P |
Bisoprolol je ordinován k léčbě srdečního selhání; v dávce 2,5 mg je určen k zahájení léčby, pouze v případech, kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 2,5 mg dlouhodobě. Cílová dávka bisoprololu v této indikaci je 10 mg denně a k udržovací léčbě možno předpisovat bisoprolol v tabletách s obsahem 10 mg. V indikaci léčby hypertenze, arytmií a sekundární prevence nelze hradit ze zdravotního pojištění.
| 153.13 | C07AB08 | celiprolol | p.o. | 0.2 | GM | 5,12 | | | 59761 | TENOLOC 200 | tbl obd 30x200mg | LEX | CZ | | | | | 153.14 | C07AB12 | nebivolol | p.o. | 5 | MG | 5,12 | | | 154 | C07AB | beta-blokátory, s beta-1 selektivitou | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1398,18 | O | | | | | | | | | | | 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 1840,83 | O | | 65387 | TENORMIN | inj sol 10x10ml/5mg | AZC | GB | | | | | 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1398,18 | O | | | | | | | | | | | 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4205,00 | O | | 58412 | BREVIBLOC 250 MG/ML | inf cnc sol 1x10ml | BXT | GB | | | | | 155 | C07AG | alfa, beta-blokátory | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 19,50 | L/KAR,INT,GER | | | | | | | | | | | 155.2 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 21,00 | P | | 98922 | ATRAM 6.25 | por tblnob30x6.25mg | LEX | CZ | | | |
Léčbu karvedilolem zahajuje kardiolog nebo internista k léčbě srdečního selhání s prokázaným snížením ejekční frakce levé srdeční komory na 35% a níže. Karvedilol v dávce 6,25 mg je určen k zavedení léčby na dobu nezbytně nutnou a je možno jej předepsat maximálně v množství 3 balení na nemocného. Pouze v případech, že není vyšší dávka tolerována, je možno podávat dávku 6,25 mg dlouhodobě. Cílová dávka karvedilolu v této indikaci je 25 - 50 mg denně. V indikaci léčby hypertenze nelze hradit z prostředků zdravotního pojištění.
| 155.3 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.5 | MG | 16,00 | P | | 98925 | ATRAM 25 | por tblnob30x25mg | LEX | CZ | | | | | 156 | C07AG | alfa, beta-blokátory | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 1027,60 | H | | 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 157.1 | C07BB03 | atenolol a thiazidy | p.o. | 1 | DF | 4,34 | | | 76715 | TENORETIC | por tbl flm 28 | AZC | GB | | | | | 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,34 | | | | | | | | | | | | 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva | p.o. | 0.5 | DF | 0,73 | | | | | | | | | | | | 157.4 | C07BB07 | bisoprolol a thiazidy | p.o. | 1 | DF | 3,71 | | | 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 5,53 | | | 02954 | AGEN 10 | por tbl nob 30x10mg | LEX | CZ | | | | | 02945 | AGEN 5 | por tbl nob 30x5mg | LEX | CZ | | | | | 58876 | AMLOZEK 10 | por tbl nob 30x10mg | ADD | PL | | | | | 58874 | AMLOZEK 5 | por tbl nob 30x5mg | ADD | PL | | | | | 03999 | CARDILOPIN 10 MG | por tbl nob 30x10mg | EGI | H | | | | | 03997 | CARDILOPIN 2.5 MG | por tbl nob30x2.5mg | EGI | H | | | | | 03998 | CARDILOPIN 5 MG | por tbl nob 30x5mg | EGI | H | | | | | 03994 | NORMODIPINE 10 MG | por tbl nob 30x10mg | GED | H | | | | | 03993 | NORMODIPINE 5 MG | por tbl nob 30x5mg | GED | H | | | | | 58417 | ORCAL 10MG | tbl 30x10mg | LEK | SLO | | | | | 58415 | ORCAL 5MG | tbl 30x5mg | LEK | SLO | | | | | 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 5,53 | | | 03965 | AURONAL 10 MG RETARD | por tbl ret 30x10mg | EGI | H | | | | | 03961 | AURONAL 2.5 MG RETARD | por tbl ret30x2.5mg | EGI | H | | | | | 03963 | AURONAL 5 MG RETARD | por tbl ret30x5mg | EGI | H | | | | | 02959 | PRESID 10 MG | por tbl ret 30x10mg | IVX | CZ | | | | | 02961 | PRESID 2.5 MG | por tbl ret30x2.5mg | IVX | CZ | | | | | 02957 | PRESID 5 MG | por tbl ret 30x5mg | IVX | CZ | | | | | 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 5,28 | | | | | | | | | | | | 158.4 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5 | MG | 5,53 | | | | | | | | | | | | 158.5 | C08CA05 | nifedipin | p.o. | 30 | MG | 1,45 | | | 91634 | CORDAFEN | por tbl flm 50x10mg | ZPF | PL | | | | | 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,10 | | | 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | | | | | 47490 | CORINFAR 20 RETARD | por tbl pro 30x20mg | AWD | D | | | | | 158.7 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,37 | | | | | | | | | | | | 158.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1 | DF | 5,53 | | | 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO | | | | | 53372 | NIFECARD XL 30MG | tbl ret 30x30mg | LEK | SLO | | | | | 158.9 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 136,08 | X | | 94189 | DILCEREN | tbl obd 50x30mg | SLO | SK | | | | | 158.10 | C08CA07 | nisoldipin | p.o. | 20 | MG | 5,53 | | | | | | | | | | | | 158.11 | C08CA08 | nitrendipin | p.o. | 20 | MG | 5,53 | | | 94688 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 30x20mg | MCK | D | | | | | 30965 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob100x20mg | MCK | D | | | | | 66469 | NITREPRESS 10 | por tbl nob 20x10mg | HHO | D | | | | | 95584 | NITREPRESS 10 | por tbl nob 28x10mg | HHO | D | | | | | 95585 | NITREPRESS 10 | por tbl nob 30x10mg | HHO | D | | | | | 66495 | NITREPRESS 10 | por tbl nob 50x10mg | HHO | D | | | | | 66496 | NITREPRESS 10 | por tbl nob100x10mg | HHO | D | | | | | 66499 | NITREPRESS 20 | por tbl nob 20x20mg | HHO | D | | | | | 95586 | NITREPRESS 20 | por tbl nob 28x20mg | HHO | D | | | | | 95587 | NITREPRESS 20 | por tbl nob 30x20mg | HHO | D | | | | | 66498 | NITREPRESS 20 | por tbl nob 50x20mg | HHO | D | | | | | 66497 | NITREPRESS 20 | por tbl nob100x20mg | HHO | D | | | | | 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO | | | | | 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO | | | | | 158.12 | C08CA09 | lacidipin | p.o. | 4 | MG | 5,53 | | | | | | | | | | | | 158.13 | C08CA10 | nilvadipin | p.o. | 8 | MG | 5,53 | | | | | | | | | | | | 158.14 | C08CA12 | barnidipin | p.o. | 10 | MG | 5,53 | | | | | | | | | | | | 158.15 | C08CA13 | lercanidipin | p.o. | 10 | MG | 5,53 | | | 158.16 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,20 | L/INT,KAR,GER | | 159 | C08CA | antagonisté vápníku dihydropyridinové řady | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 159.1 | C08CA03 | isradipin | parent. | 5 | MG | 3074,59 | H | | | | | | | | | | | 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3074,59 | H | | | | | | | | | | | 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3066,90 | X | | 94535 | NIMOTOP S | inf sol 5x50ml/10mg | BAY | D | | | | | 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 160.1 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 5,00 | | | 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D | | | | | 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | | | | | 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | | | | | 56154 | VERAHEXAL 40 | tbl obd 100x40mg | FST | D | | | | | 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D | | | | | 56153 | VERAHEXAL 40 | tbl obd 50x40mg | FST | D | | | | | 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D | | | | | 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D | | | | | 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D | | | | | 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D | | | | | 56161 | VERAHEXAL KHK RETARD | tbl ret 30x120mg | FST | D | | | | | 56162 | VERAHEXAL KHK RETARD | tbl ret 50x120mg | FST | D | | | | | 99305 | VERAPAMIL 40-SLOVAKOFARMA | tbl obd 30x40mg | SLO | SK | | | | | 99306 | VERAPAMIL 80-SLOVAKOFARMA | tbl obd 30x80mg | SLO | SK | | | | | 86045 | VERAPAMIL AL 120 | por tbl flm50x120mg | APA | D | | | | | 86046 | VERAPAMIL AL 120 | por tblflm100x120mg | APA | D | | | | | 77034 | VERAPAMIL AL 40 | por tbl flm50x40mg | APA | D | | | | | 77035 | VERAPAMIL AL 40 | por tblflm100x40mg | APA | D | | | | | 77036 | VERAPAMIL AL 80 | por tbl flm50x80mg | APA | D | | | | | 77037 | VERAPAMIL AL 80 | por tblflm100x80mg | APA | D | | | | | 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 5,53 | | | 93679 | LEKOPTIN RETARD | tbl ret 20x240mg | LEK | SLO | | | | | 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D | | | | | 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D | | | | | 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D | | | | | 54032 | VERAPAMIL AL 240 RETARD | por tbl ret50x240mg | APA | D | | | | | 54034 | VERAPAMIL AL 240 RETARD | por tblret100x240mg | APA | D | | | | | 43877 | VEROGALID ER 240 MG | por tblpro 30x240mg | IVX | CZ | | | | | 43879 | VEROGALID ER 240 MG | portblpro 100x240mg | IVX | CZ | | | | | 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,00 | | | 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 355,24 | H | | 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,28 | | | 93186 | BLOCALCIN 60 | por tbl nob 50x60mg | PVL | CZ | | | | | 94321 | BLOCALCIN 90 RETARD | por tbl ret 30x90mg | PVL | CZ | | | | | 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,53 | | | 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 319,18 | H | | 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,29 | | | 97873 | ALKADIL 25MG | tbl 40x25mg | ALK | MAC | | | | | 96903 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | APT | CND | | | | | 68839 | APO-CAPTO 25 MG | tbl 100x25mg | APT | CND | | | | | 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | | | | | 12150 | CAPTOPRIL AL 12.5 | tbl 100x12.5mg | APA | D | | | | | 12148 | CAPTOPRIL AL 12.5 | tbl 30x12.5mg | APA | D | | | | | 12149 | CAPTOPRIL AL 12.5 | tbl 50x12.5mg | APA | D | | | | | 164.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,00 | | | 59381 | CAPTOPRIL 25 SVUS | tbl 100x25mg | SVS | CZ | | | | | 32253 | CAPTOPRIL AL 25 | tbl 100x25mg | APA | D | | | | | 32251 | CAPTOPRIL AL 25 | tbl 30x25mg | APA | D | | | | | 32252 | CAPTOPRIL AL 25 | tbl 50x25mg | APA | D | | | | | 164.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 3,80 | | | 59386 | CAPTOPRIL 50 SVUS | tbl 100x50mg | SVS | CZ | | | | | 59384 | CAPTOPRIL 50 SVUS | tbl 30x50mg | SVS | CZ | | | | | 59385 | CAPTOPRIL 50 SVUS | tbl 50x50mg | SVS | CZ | | | | | 84143 | CAPTOPRIL AL 50 | tbl 100x50mg | APA | D | | | | | 84141 | CAPTOPRIL AL 50 | tbl 30x50mg | APA | D | | | | | 84142 | CAPTOPRIL AL 50 | tbl 50x50mg | APA | D | | | | | 49563 | TENSIOMIN 50MG | tbl 90x50mg | EGI | H | | | | | 164.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 4,95 | | | 83503 | APO-ENALAPRIL 5 MG | tbl 100x5mg | APQ | MEX | | | | | 59108 | BERLIPRIL 5 | tbl 100x5mg | BCE | D | | | | | 84651 | BERLIPRIL 5 | tbl 30x5mg | BCE | D | | | | | 32179 | E-COR 2.5 | por tbl nob30x2.5mg | SLO | SK | | | | | 32183 | E-COR 5 | por tbl nob 100x5mg | SLO | SK | | | | | 32182 | E-COR 5 | por tbl nob 30x5mg | SLO | SK | | | | | 11991 | EDNYT 2.5 MG | tbl 30x2.5mg | GED | H | | | | | 32277 | EDNYT 5 MG | tbl 100x5mg-blistr | GED | H | | | | | 12087 | EDNYT 5 MG | tbl 30x5mg-blistr | GED | H | | | | | 66115 | ENALAPRIL 2.5-SL | tbl 100x2.5mg(bli.) | SLO | SK | | | | | 66067 | ENALAPRIL 2.5-SL | tbl 30x2.5mg(blis.) | SLO | SK | | | | | 66197 | ENALAPRIL 5-SL | tbl 100x5mg(blis.) | SLO | SK | | | | | 66148 | ENALAPRIL 5-SL | tbl 30x5mg(blistr) | SLO | SK | | | | | 32758 | ENALEK 5 MG | por tbl nob 30x5mg | LEK | SLO | | | | | 06550 | ENAP 2.5MG | tbl 100x2.5mg | KRK | SLO | | | | | 59976 | ENAP 2.5MG | tbl 30x2.5mg | KRK | SLO | | | | | 45273 | ENAP 5 MG | por tbl nob 30x5mg | KRK | SLO | | | | | 59643 | ENAP 5 MG | por tbl nob100x5mg | KRK | SLO | | | | | 30478 | ENAPIREX 5 MG | por tbl nob 28x5mg | CHN | H | | | | | 42632 | ENAPIREX 5 MG | por tbl nob 70x5mg | CHN | H | | | | | 59879 | ENAPRIL 5 | tbl 100x5mg | SFS | D | | | | | 59877 | ENAPRIL 5 | tbl 30x5mg | SFS | D | | | | | 59878 | ENAPRIL 5 | tbl 50x5mg | SFS | D | | | | | 164.5 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 3,90 | | | 64839 | APO-ENALAPRIL 10 MG | tbl 100x10mg | APQ | MEX | | | | | 32185 | E-COR 10 | por tbl nob 30x10mg | SLO | SK | | | | | 32186 | E-COR 10 | por tblnob100x10mg | SLO | SK | | | | | 32276 | EDNYT 10 MG | tbl 100x10mg-blistr | GED | H | | | | | 12156 | EDNYT 10 MG | tbl 30x10mg-blistr | GED | H | | | | | 58052 | ENALAPRIL 10-SL | tbl 100x10mg(blis.) | SLO | SK | | | | | 58055 | ENALAPRIL 10-SL | tbl 30x10mg(blistr) | SLO | SK | | | | | 58367 | ENALAPRIL-RATIOPHARM 10 MG | tbl 50x10mg | MCK | D | | | | | 32759 | ENALEK 10 MG | por tbl nob 30x10mg | LEK | SLO | | | | | 45274 | ENAP 10 MG | por tbl nob 30x10mg | KRK | SLO | | | | | 59642 | ENAP 10 MG | por tbl nob100x10mg | KRK | SLO | | | | | 30479 | ENAPIREX 10 MG | por tbl nob 28x10mg | CHN | H | | | | | 42636 | ENAPIREX 10 MG | por tbl nob 70x10mg | CHN | H | | | | | 59882 | ENAPRIL 10 | tbl 100x10mg | SFS | D | | | | | 59880 | ENAPRIL 10 | tbl 30x10mg | SFS | D | | | | | 59881 | ENAPRIL 10 | tbl 50x10mg | SFS | D | | | | | 164.6 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10 MG | 2,85 | | | | 64840 | APO-ENALAPRIL 20 MG | tbl 100x20mg | APQ | MEX | | | | | 32188 | E-COR 20 | por tbl nob 30x20mg | SLO | SK | | | | | 32189 | E-COR 20 | por tblnob100x20mg | SLO | SK | | | | | 12212 | EDNYT 20 MG | tbl 30x20mg | GED | H | | | | | 58061 | ENALAPRIL 20-SL | tbl 30x20mg(blistr) | SLO | SK | | | | | 58369 | ENALAPRIL-RATIOPHARM 20 MG | tbl 30x20mg | MCK | D | | | | | 32760 | ENALEK 20 MG | por tbl nob 30x20mg | LEK | SLO | | | | | 45275 | ENAP 20 MG | por tbl nob 30x20mg | KRK | SLO | | | | | 30480 | ENAPIREX 20 MG | por tbl nob 28x20mg | CHN | | | | | | 42640 | ENAPIREX 20 MG | por tbl nob 70x20mg | CHN | | | | | | 59885 | ENAPRIL 20 | tbl 100x20mg | SFS | D | | | | | 59883 | ENAPRIL 20 | tbl 30x20mg | SFS | D | | | | | 59884 | ENAPRIL 20 | tbl 50x20mg | SFS | D | | | | | 164.7 | C09AA03 | lisinopril | p.o. | 10 | MG | 5,13 | | | 10685 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | | | | | 10629 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | | | | | 164.8 | C09AA04 | perindopril | p.o. | 4 | MG | 6,00 | | | 164.9 | C09AA05 | ramipril do 2,5 mg v jedné tabletě včetně | p.o. | 2.5 | MG | 6,00 | | | 13469 | RAMIL 1.25 | por tblnob30x1.25mg | LEX | CZ | | | | | 13470 | RAMIL 1.25 | por tblnob90x1.25mg | LEX | CZ | | | | | 13472 | RAMIL 2.5 | por tblnob 30x2.5mg | LEX | CZ | | | | | 13473 | RAMIL 2.5 | por tblnob 90x2.5mg | LEX | CZ | | | | | 164.10 | C09AA05 | ramipril nad 2,5 mg v jedné tabletě | p.o. | 2.5 | MG | 4,80 | | | 13477 | RAMIL 10 | por tblnob 30x10mg | LEX | CZ | | | | | 13478 | RAMIL 10 | por tblnob 90x10mg | LEX | CZ | | | | | 164.11 | C09AA06 | quinapril do 15 mg v jedné tabletě včetně | p.o. | 15 | MG | 6,00 | | | | | | | | | | | | 164.12 | C09AA06 | quinapril nad 15 mg v jedné tabletě | p.o. | 15 | MG | 4,80 | | | | | | | | | | | | 164.13 | C09AA07 | benazepril | p.o. | 7.5 | MG | 6,00 | | | | | | | | | | | | 164.14 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 6,00 | | | | | | | | | | | | 164.15 | C09AA09 | fosinopril | p.o. | 15 | MG | 4,80 | | | | | | | | | | | | 164.16 | C09AA10 | trandolapril | p.o. | 2 | MG | 6,00 | | | | | | | | | | | | 164.17 | C09AA11 | spirapril | p.o. | 6 | MG | 6,00 | | | | | | | | | | | | 164.18 | C09AA12 | delapril | p.o. | 30 | MG | 6,00 | | | | | | | | | | | | 164.19 | C09AA13 | moexipril | p.o. | 15 | MG | 6,00 | | | | | | | | | | | | 164.20 | C09AA16 | imidapril do 5 mg v jedné tabletě včetně | p.o. | 5 | MG | 6,00 | | | | | | | | | | | | 164.21 | C09AA16 | imidapril nad 5 mg v jedné tabletě | p.o. | 5 | MG | 4,80 | | | 165 | C09AA | inhibitory angiotenzin konvertujíciho enzymu | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 26,30 | H | | 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO | | | | | 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 4,78 | | | 53252 | CAPTOHEXAL COMP.25/12.5 | tbl 100x25mg/12.5mg | SFS | D | | | | | 53250 | CAPTOHEXAL COMP.25/12.5 | tbl 20x25mg/12.5mg | SFS | D | | | | | 53251 | CAPTOHEXAL COMP.25/12.5 | tbl 50x25mg/12.5mg | SFS | D | | | | | 53245 | CAPTOHEXAL COMP.25/25 | tbl 100x25mg/25mg | SFS | D | | | | | 53242 | CAPTOHEXAL COMP.25/25 | tbl 20x25mg/25mg | SFS | D | | | | | 53243 | CAPTOHEXAL COMP.25/25 | tbl 50x25mg/25mg | SFS | D | | | | | 53249 | CAPTOHEXAL COMP.50/25 | tbl 100x50mg/25mg | SFS | D | | | | | 53246 | CAPTOHEXAL COMP.50/25 | tbl 20x50mg/25mg | SFS | D | | | | | 53248 | CAPTOHEXAL COMP.50/25 | tbl 50x50mg/25mg | SFS | D | | | | | 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 4,37 | | | 66506 | ENAP-H | por tbl nob 30 | KRK | SLO | | | | | 55429 | ENAP-HL | por tbl nob 30 | KRK | SLO | | | | | 166.3 | C09BA06 | quinapril s obsahem 10 mg v jedné tabletě a diuretikum | p.o. | 1 | DF | 4,47 | | | | | | | | | | | | 166.4 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum | p.o. | 1 | DF | 6,87 | | | | | | | | | | | | 166.5 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 5,06 | | | | | | | | | | | | 166.6 | C09BA08 | cilazapril a diuretika | p.o. | 1 | DF | 10,07 | | | | | | | | | | | | 166.7 | C09BB05 | felodipin a ramipril | p.o. | 1 | DF | 8,77 | | | | | | | | | | | | 166.8 | C09BB10 | trandolapril/verapamil | p.o. | 1 | DF | 9,75 | | | 167 | C09CA | antagonisté angiotensinu II | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 167.1 | C09CA01 | losartan do 50 mg v jedné tabletě včetně | p.o. | 50 | MG | 6,50 | | | 10604 | LORISTA | por tblflm 28x50mg | KRK | SLO | | | | | 47610 | LORISTA | por tblflm 84x50mg | KRK | SLO | | | | | 10618 | LOZAP 12.5 | portblflm 30x12.5mg | LEX | CZ | | | | | 10620 | LOZAP 50 | por tbl flm 30x50mg | LEX | CZ | | | | | 167.2 | C09CA01 | losartan nad 50 mg v jedné tabletě včetně | p.o. | 50 | MG | 5,20 | | | | | | | | | | | | 167.3 | C09CA02 | eprosartan | p.o. | 600 | MG | 6,50 | | | | | | | | | | | | 167.4 | C09CA03 | valsartan do 80 mg v jedné tabletě včetně | p.o. | 80 | MG | 6,50 | | | | | | | | | | | | 167.5 | C09CA03 | valsartan nad 80 mg v jedné tabletě | p.o. | 80 | MG | 5,20 | | | | | | | | | | | | 167.6 | C09CA04 | irbesartan do 150 mg v jedné tabletě včetně | p.o. | 150 | MG | 9,00 | P | | | | | | | | | | | 167.7 | C09CA04 | irbesartan nad 150 mg v jedné tabletě | p.o. | 150 | MG | 7,20 | P |
Irbesartan je indikován u pacientů s:
- a) diabetickou nefropatie již od fáze mikroalbuminurie
- b) nediabetickou nefropatie s proteinurií vyšší než 1 g/24 hodin u nemocných netolerujících inhibitory ACE
| 167.8 | C09CA06 | kandesartan do 8 mg v jedné tabletě včetně | p.o. | 8 | MG | 6,50 | |
|---|---|---|---|---|---|---|---|
| 167.9 | C09CA06 | kandesartan nad 8 mg v jedné tabletě | p.o. | 8 | MG | 5,20 | |
| 167.10 | C09CA07 | telmisartan do 40 mg v jedné tabletě včetně | p.o. | 40 | MG | 6,50 | |
| 167.11 | C09CA07 | telmisartan nad 40 mg v jedné tabletě | p.o. | 40 | MG | 5,20 | |
| 167.12 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 6,97 | |
| 03701 | LOZAP H | por tbl flm 28 | LEX | CZ | |||
| 167.13 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 80 mg valsartanu v jedné tabletě včetně | p.o. | 1 | DF | 6,97 | |
| 167.14 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 12,5 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1 | DF | 10,87 | |
| 167.15 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 25 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1 | DF | 11,34 | |
| 167.16 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 8 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 6,97 | |
| 167.17 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 16 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 10,87 | |
| 167.18 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 40 mg telmisartanu v jedné tabletě | p.o. | 1 | DF | 6,97 | |
| 167.19 | C09DA07 | telmisartan v kombinaci s thiazidy s obsahem 80 mg telmisartanu v jedné tabletě | p.o. | 1 | DF | 10,87 | |
| 168 | C10AA | hypolipidemika ze skupiny statinů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
Simvastatin, lovastatin: léčba nemocných s manifestní aterosklerózou (sekundární prevence) s izolovanou hypercholesterolémií nebo se smíšenou hyperlipidémií s převahou hypercholesterolémie, možno předepsat vždy jen jedno hypolipidemikum (nelze kombinovat statiny a fibráty). U pacientů s diabetes mellitus s hypercholesterolémií též indikován v primární prevenci.
Léčba atorvastatinem, cerivastatinem, fluvastatinem a pravastatinem ordinuje kardiolog, internista, diabetolog nebo lékař pracující v poradnách pro poruchy metabolizmu lipidů:
- a) léčba nemocných s familiární hypercholesterolémií (atorvastatin v dávce 40mg denně je hrazen pouze v léčbě nemocných s isolovanou familiární hypercholesterolemií)
- b) léčba nemocných s manifestní aterosklerózou (sekundární prevence) s izolovanou hypercholesterolémií nebo s kombinovanou hyperlipidémií s převahou hypercholesterolémie
- c) léčba nemocných s kumulací rizikových faktorů (s vysokým rizikem kardiovaskulární příhody vyjádřeným absolutním desetiletým rizikem 20% a více ) s izolovanou hypercholesterolémií či s kombinovanou hyperlipidémií s převahou hypercholesterolémie
| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,00 | P | | 59727 | SIMGAL 10 MG | por tbl flm 28x10mg | IVX | CZ | | | | | 10390 | SIMIREX 10 MG | por tbl flm 30x10mg | SYH | E | | | | | 10398 | SIMIREX 10 MG | por tbl flm 50x10mg | SYH | E | | | | | 58773 | SIMVACARD 10 | tbl obd 28x10mg | LEX | CZ | | | | | 31844 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | SYH | E | | | | | 31847 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm100x10mg | SYH | E | | | | | 49919 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D | | | | | 49923 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D | | | | | 81479 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK | | | | | 97067 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK | | | | | 49920 | SIMVAX 10 | por tbl flm 30x10mg | SFS | D | | | | | 49924 | SIMVAX 10 | por tbl flm 30x10mg | SFS | D | | | | | 81480 | SIMVAX 10 | por tbl flm 30x10mg | GEA | DK | | | | | 97068 | SIMVAX 10 | por tbl flm 30x10mg | GEA | DK | | | | | 49921 | SIMVAX 10 | por tbl flm 50x10mg | SFS | D | | | | | 49925 | SIMVAX 10 | por tbl flm 50x10mg | SFS | D | | | | | 81481 | SIMVAX 10 | por tbl flm 50x10mg | GEA | DK | | | | | 97069 | SIMVAX 10 | por tbl flm 50x10mg | GEA | DK | | | | | 49922 | SIMVAX 10 | por tbl flm100x10mg | SFS | D | | | | | 49926 | SIMVAX 10 | por tbl flm100x10mg | SFS | D | | | | | 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND | | | | | 58136 | VASILIP 10 | tbl obd 28x10mg | KRK | SLO | | | | | 95250 | VASILIP 10 | tbl obd 84x10mg | KRK | SLO | | | | | 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 16,00 | P | | 59728 | SIMGAL 20 MG | por tbl flm 28x20mg | IVX | CZ | | | | | 10422 | SIMIREX 20 MG | por tbl flm 30x20mg | SYH | E | | | | | 58775 | SIMVACARD 20 | tbl obd 28x20mg | LEX | CZ | | | | | 47731 | SIMVACARD 20 | tbl obd 84x20mg | LEX | CZ | | | | | 31851 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | SYH | E | | | | | 31856 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100x20mg | SYH | E | | | | | 49911 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D | | | | | 49915 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D | | | | | 81483 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK | | | | | 97071 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK | | | | | 49912 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D | | | | | 49916 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D | | | | | 81484 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK | | | | | 97072 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK | | | | | 49913 | SIMVAX 20 | por tbl flm 50x20mg | SFS | D | | | | | 49917 | SIMVAX 20 | por tbl flm 50x20mg | SFS | D | | | | | 81485 | SIMVAX 20 | por tbl flm 50x20mg | GEA | DK | | | | | 97073 | SIMVAX 20 | por tbl flm 50x20mg | GEA | DK | | | | | 49914 | SIMVAX 20 | por tbl flm100x20mg | SFS | D | | | | | 49918 | SIMVAX 20 | por tbl flm100x20mg | SFS | D | | | | | 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND | | | | | 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO | | | | | 95251 | VASILIP 20 | tbl obd 84x20mg | KRK | SLO | | | | | 168.3 | C10AA01 | simvastatin (nad 20 mg do 40mg v jedné tabletě včetně) | p.o. | 1 | DF | 25,60 | P | | 59729 | SIMGAL 40 MG | por tbl flm 28x40mg | IVX | CZ | | | | | 10459 | SIMIREX 40 MG | por tbl flm 30x40mg | SYH | E | | | | | 58777 | SIMVACARD 40 | tbl obd 28x40mg | LEX | CZ | | | | | 31859 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | SYH | E | | | | | 49901 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D | | | | | 49905 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D | | | | | 81487 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK | | | | | 97075 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK | | | | | 49902 | SIMVAX 40 | por tbl flm 30x40mg | SFS | D | | | | | 49906 | SIMVAX 40 | por tbl flm 30x40mg | SFS | D | | | | | 81488 | SIMVAX 40 | por tbl flm 30x40mg | GEA | DK | | | | | 97076 | SIMVAX 40 | por tbl flm 30x40mg | GEA | DK | | | | | 49903 | SIMVAX 40 | por tbl flm 50x40mg | SFS | D | | | | | 49907 | SIMVAX 40 | por tbl flm 50x40mg | SFS | D | | | | | 81489 | SIMVAX 40 | por tbl flm 50x40mg | GEA | DK | | | | | 97077 | SIMVAX 40 | por tbl flm 50x40mg | GEA | DK | | | | | 49904 | SIMVAX 40 | por tbl flm100x40mg | SFS | D | | | | | 49908 | SIMVAX 40 | por tbl flm100x40mg | SFS | D | | | | | 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | | | | | 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | | | | | 42929 | VASILIP 40 | por tbl obd 28x40mg | KRK | SLO | | | | | 168.4 | C10AA01 | simvastatin (nad 40 mg v jedné tabletě) | p.o. | 1 | DF | 40,90 | P | | | | | | | | | | | 168.5 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 9,00 | P | | 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND | | | | | 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND | | | | | 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO | | | | | 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY | | | | | 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY | | | | | 168.6 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1 | DF | 14,40 | P | | 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND | | | | | 01254 | APO-LOVASTATIN 40 | tbl 30x40mg | APT | CND | | | | | 168.7 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,00 | P | | | | | | | | | | | 168.8 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 16,00 | P | | | | | | | | | | | 168.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě) | p.o. | 1 | DF | 25,60 | P | | | | | | | | | | | 168.10 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,00 | P | | | | | | | | | | | 168.11 | C10AA04 | fluvastatin (nad 20 mg do 40 mgv jedné tabletě včetně) | p.o. | 1 | DF | 16,00 | P | | | | | | | | | | | 168.12 | C10AA04 | fluvastatin (nad 40 MG v jedné tabletě ) | p.o. | 1 | DF | 27,50 | P | | | | | | | | | | | 168.13 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 21,40 | P | | | | | | | | | | | 168.14 | C10AA05 | atorvastatin (nad 10 MG do 20 MG v jedné tabletě včetně) | p.o. | 1 | DF | 34,20 | P | | | | | | | | | | | 168.15 | C10AA05 | atorvastatin (nad 20 MG do 40 MG v jedné tabletě včetně) | p.o. | 1 | DF | 54,70 | P | | 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 169.1 | C10AB | klofibrát (etofylin) | p.o. | 0.5 | GM | 4,55 | | | 49609 | DUOLIP FORTE | tbl obd 100x500mg | MCK | D | | | | | 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 6,50 | | | | | | | | | | | | 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 6,50 | | | | | | | | | | | | 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 6,50 | | | | | | | | | | | | 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1 | DF | 8,10 | | | 04143 | APO-FENO | por cpsdur 30x200mg | APT | CND | | | | | 04145 | APO-FENO | por cpsdur100x200mg | APT | CND | | | | | 32652 | FEBIRA 200 | por cps dur30x200mg | SLO | SK | | | | | 32653 | FEBIRA 200 | por cps dur60x200mg | SLO | SK | | | | | 32654 | FEBIRA 200 | por cps dur90x200mg | SLO | SK | | | | | 41797 | LIPIREX 200MG | por cps dur60x200mg | SGY | B | | | | | 99839 | LIPIREX S 160 MG | por cps dur60x160mg | SGY | B | | | | | 47872 | SUPRELIP | por cps dur30x200mg | CPW | H | | | | | 47873 | SUPRELIP | por cpsdur100x200mg | CPW | H | | | | | 169.6 | C10AB05 | fenofibrát (supramikronisované lékové formy) | p.o. | 1 | DF | 9,00 | | | | | | | | | | | | 169.7 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 8,10 | | | | | | | | | | | | 169.8 | C10AD06 | acipimox | p.o. | 500 | MG | 11,15 | | | 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje kardiolog, internista nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:
- a) léčba pacientů s hyperlipoproteinemií s vysokou hladinou cholesterolu,
- b) léčba pacientů s pruritem při biliární cirhóze.
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)